Studies of the Taiwanese mouse model of severe SMA have also found evidence to suggest that reduced SMN levels impact other developmental processes, including lung, intestine, heart and longitudinal bone growth [23,24,25]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.